Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
Chembiochem : a European Journal of Chemical Biology
|
March 5, 2003
D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity
Karl A Hansford, Robert C Reid, Chris I Clark, et al.
Journal of Leukocyte Biology
|
November 23, 2021
The histone deacetylase Hdac7 supports LPS-inducible glycolysis and Il-1β production in murine macrophages via distinct mechanisms
Divya Ramnath, Kaustav Das Gupta, Yizhuo Wang, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
September 24, 2021
Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice
Ming Jang Chua, Jiahui Tng, Eva Hesping, et al.
Disease Models & Mechanisms
|
May 23, 2018
Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis
Soo-Hyun Kim, Richard P Redvers, Lap Hing Chi, et al.
Scientific Reports
|
April 21, 2016
Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists
Vernon Seow, Junxian Lim, Adam J Cotterell, et al.
Molecular Pharmacology
|
March 27, 2004
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity
Darren R March, Lavinia M Proctor, Martin J Stoermer, et al.
Nature Communications
|
November 22, 2013
Downsizing a human inflammatory protein to a small molecule with equal potency and functionality
Robert C Reid, Mei-Kwan Yau, Ranee Singh, et al.
ACS Medicinal Chemistry Letters
|
December 21, 2016
PAR2 Modulators Derived from GB88
Mei-Kwan Yau, Ligong Liu, Jacky Y Suen, et al.
British Journal of Pharmacology
|
June 26, 2019
Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic type 2 inflammation
Zhixuan Loh, Rebecca L Fitzsimmons, Robert C Reid, et al.
Journal of Medicinal Chemistry
|
January 8, 2020
Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity
Jessica A Rowley, Robert C Reid, Eunice K Y Poon, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
Chembiochem : a European Journal of Chemical Biology
|
March 5, 2003
D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity
Karl A Hansford, Robert C Reid, Chris I Clark, et al.
Journal of Leukocyte Biology
|
November 23, 2021
The histone deacetylase Hdac7 supports LPS-inducible glycolysis and Il-1β production in murine macrophages via distinct mechanisms
Divya Ramnath, Kaustav Das Gupta, Yizhuo Wang, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
September 24, 2021
Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice
Ming Jang Chua, Jiahui Tng, Eva Hesping, et al.
Disease Models & Mechanisms
|
May 23, 2018
Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis
Soo-Hyun Kim, Richard P Redvers, Lap Hing Chi, et al.
Scientific Reports
|
April 21, 2016
Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists
Vernon Seow, Junxian Lim, Adam J Cotterell, et al.
Molecular Pharmacology
|
March 27, 2004
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity
Darren R March, Lavinia M Proctor, Martin J Stoermer, et al.
Nature Communications
|
November 22, 2013
Downsizing a human inflammatory protein to a small molecule with equal potency and functionality
Robert C Reid, Mei-Kwan Yau, Ranee Singh, et al.
ACS Medicinal Chemistry Letters
|
December 21, 2016
PAR2 Modulators Derived from GB88
Mei-Kwan Yau, Ligong Liu, Jacky Y Suen, et al.
British Journal of Pharmacology
|
June 26, 2019
Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic type 2 inflammation
Zhixuan Loh, Rebecca L Fitzsimmons, Robert C Reid, et al.
Journal of Medicinal Chemistry
|
January 8, 2020
Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity
Jessica A Rowley, Robert C Reid, Eunice K Y Poon, et al.
Page
of 8